As we transition out of the COVID-19 era, the unforeseen changes that were enforced due to the pandemic continue to reverberate legally and financially throughout various domains, a case in point being the Medicaid Redeterminations. For the uninitiated, well into March 2020, as the pandemic swept across nations and economies went into partial or full shutdowns, the U.S. Congress took several preventive measures to ensure continuous access to health coverage.
Notably, Medicaid, a critical public health insurance program in the United States, received significant support from the Congress in two interlinked ways. First, the federal share of Medicaid funding was ramped up. Second, the Congress underpinned the access to this service by ensuring that individuals would remain enrolled in Medicaid throughout the public health emergency (PHE), irrespective of any changes in their circumstances that would otherwise make them ineligible.
As things inched towards a semblance of normalcy, the Medicaid continuous enrollment requirements were relaxed and the states are now tasked with Medicaid redeterminations. These redeterminations aim to reassess the eligibility of those individuals who are currently enrolled in Medicaid.
For legal professionals treading the healthcare law domain or advising clients therein, it would be prudent to stay abreast of any development in this landscape. The full article detailing this scenario can be read at JD Supra, which also discusses the respective effects of Medicaid redeterminations on states and enrollees, and delves into how the state officials are now handling the Medicaid program.
As the pandemic ramifications continue to unfold, such issues could lead to significant changes in healthcare law, and an understanding of the same is pivotal for legal professionals working at corporations and law firms.